Mucosal microbiota of intestinal polyps reveals putative biomarkers of colorectal cancer

Abstract

The human intestine retains a complex microbial ecosystem, which performs crucial functions that impact on host health. Several studies have indicated that intestinal dysbiosis may impact on the establishment of life-threatening intestinal diseases such as colorectal cancer. An adenomatous polyp is the result of abnormal tissue growth, which is benign but is considered to be associated with a high risk of developing colorectal cancer, based on its grade of dysplasia. Development of diagnostic tools that are based on surveying the gut microbiota and are aimed at early detection of colorectal cancer represent highly desirable target. For this purpose, we performed a pilot study in which we applied a metataxonomic analysis based on 16S rRNA gene sequencing approach to unveil the composition of microbial communities of intestinal polyps. Moreover, we performed a meta-analysis involving the reconstructed microbiota composition of adenomatous polyps and publicly available metagenomics datasets of colorectal cancer. These analyses allowed the identification of microbial taxa such as Faecalibacterium , Bacteroides and Romboutsia , which appear to be depleted in cancerogenic mucosa as well as in adenomatous polyps, thus representing novel microbial biomarkers associated with early tumor formation. Furthermore, an absolute quantification of Fusubacterium nucleatum in polyps further compounded the important role of this microorganism as a valuable putative microbial biomarker for early diagnosis of colorectal cancer.

References 72

1. 1.

   Fenoglio CM, Lane N. The anatomical precursor of colorectal carcinoma. Cancer. 1974;34:suppl: 819-823.

   Not in our library10.1002/1097-0142(197409)34:3+<819::aid-cncr2820340706>3.0.co;2-s

2. 2.

   Leslie A, Carey FA, Pratt NR, Steele RJ. The colorectal adenoma-carcinoma sequence. Br J Surg. 2002;89:845-860.

   Not in our library10.1046/j.1365-2168.2002.02120.x

3. 3.

   Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol. 2005;16:481-488.

   Not in our library10.1093/annonc/mdi098

4. 4.

   Lieberman D, Moravec M, Holub J, Michaels L, Eisen G. Polyp size and advanced histology in patients undergoing colonoscopy screening: implications for CT colonography. Gastroenterology. 2008;135:1100-1105.

   Not in our library10.1053/j.gastro.2008.06.083

5. 5.

   Grady WM, Markowitz SD. The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening. Dig Dis Sci. 2015;60:762-772.

   Not in our library10.1007/s10620-014-3444-4

6. 6.
   Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer · 2017

   No notice
7. 7.

   Mandal P. Potential biomarkers associated with oxidative stress for risk assessment of colorectal cancer. Naunyn Schmiedebergs Arch Pharmacol. 2017;390:557-565.

   Not in our library10.1007/s00210-017-1352-9

8. 8.

   Huycke MM, Gaskins HR. Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med (Maywood). 2004;229:586-597.

   Not in our library10.1177/153537020422900702

9. 9.

   Garrett WS. Cancer and the microbiota. Science. 2015;348:80-86.

   Not in our library10.1126/science.aaa4972

10. 10.

    Zitvogel L, Daillere R, Roberti MP, Routy B, Kroemer G. Anticancer effects of the microbiome and its products. Nat Rev Microbiol. 2017;15:465-478.

    Not in our library10.1038/nrmicro.2017.44

11. 11.

    Smith EA, Macfarlane GT. Formation of Phenolic and Indolic Compounds by Anaerobic Bacteria in the Human Large Intestine. Microb Ecol. 1997;33:180-188.

    Not in our library10.1007/s002489900020

12. 12.

    Lax AJ. Opinion: Bacterial toxins and cancer–a case to answer? Nat Rev Microbiol. 2005;3:343-349.

    Not in our library10.1038/nrmicro1130

13. 13.

    Gounaris E, et al. Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci USA. 2007;104:19977-19982.

    Not in our library10.1073/pnas.0704620104

14. 14.

    Gounaris E, et al. Live imaging of cysteine-cathepsin activity reveals dynamics of focal inflammation, angiogenesis, and polyp growth. PLoS One. 2008;3:e2916.

    Not in our library10.1371/journal.pone.0002916

15. 15.

    Gounaris E, et al. T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis. Cancer Res. 2009;69:5490-5497.

    Not in our library10.1158/0008-5472.can-09-0304

16. 16.

    Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014;12:661-672.

    Not in our library10.1038/nrmicro3344

17. 17.

    Bonnet M, et al. Colonization of the human gut by E. coli and colorectal cancer risk. Clin Cancer Res. 2014;20:859-867.

    Not in our library10.1158/1078-0432.ccr-13-1343

18. 18.

    Collins D, Hogan AM, Winter DC. Microbial and viral pathogens in colorectal cancer. The Lancet. Oncology. 2011;12:504-512.

    Not in our library10.1016/s1470-2045(10)70186-8

19. 19.

    Swidsinski A, et al. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology. 1998;115:281-286.

    Not in our library10.1016/s0016-5085(98)70194-5

20. 20.

    Nam JH, et al. Helicobacter pylori infection is an independent risk factor for colonic adenomatous neoplasms. Cancer causes & control: CCC. 2017;28:107-115.

    Not in our library10.1007/s10552-016-0839-x

21. 21.
    Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia · 2017

    No notice
22. 22.

    Scanlan PD, et al. Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol. 2008;10:789-798.

    Not in our library10.1111/j.1462-2920.2007.01503.x

23. 23.

    Doorakkers, E., Lagergren, J., Engstrand, L. & Brusselaers, N. Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population. Gut, 10.1136/gutjnl-2017-315363 (2018).

    Not in our library10.1136/gutjnl-2017-315363

24. 24.

    Chung, L. et al. Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells. Cell Host Microbe, 10.1016/j.chom.2018.01.007 (2018).

    Not in our library10.1016/j.chom.2018.02.004

25. 25.

    Eklof V, et al. Cancer-associated fecal microbial markers in colorectal cancer detection. Int J Cancer. 2017;141:2528-2536.

    Not in our library10.1002/ijc.31011

26. 26.

    Aymeric L, et al. Colorectal cancer specific conditions promote Streptococcus gallolyticus gut colonization. Proc Natl Acad Sci USA. 2018;115:E283-E291.

    Not in our library10.1073/pnas.1715112115

27. 27.

    Hale, V. L. et al. Shifts in the Fecal Microbiota Associated with Adenomatous Polyps. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 26, 85–94, 10.1158/1055-9965.EPI-16-0337 (2017).

    Not in our library10.1158/1055-9965.epi-16-0337

28. 28.
    The gut microbiota in conventional and serrated precursors of colorectal cancer · 2016

    Corrected
29. 29.

    Durban A, et al. Assessing gut microbial diversity from feces and rectal mucosa. Microb Ecol. 2011;61:123-133.

    Not in our library10.1007/s00248-010-9738-y

30. 30.

    Ouwehand AC, Salminen S, Arvola T, Ruuska T, Isolauri E. Microbiota composition of the intestinal mucosa: association with fecal microbiota? Microbiol Immunol. 2004;48:497-500.

    Not in our library10.1111/j.1348-0421.2004.tb03544.x

31. 31.

    Geng J, Fan H, Tang X, Zhai H, Zhang Z. Diversified pattern of the human colorectal cancer microbiome. Gut pathogens. 2013;5:2.

    Not in our library10.1186/1757-4749-5-2

32. 32.
    Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment · 2015

    No notice
33. 33.

    Kostic AD, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012;22:292-298.

    Not in our library10.1101/gr.126573.111

34. 34.
    Assessing the Fecal Microbiota: An Optimized Ion Torrent 16S rRNA Gene-Based Analysis Protocol · 2013

    No notice
35. 35.

    Caporaso JG, et al. QIIME allows analysis of high-throughput community sequencing data. Nature methods. 2010;7:335-336.

    Not in our library10.1038/nmeth.f.303

36. 36.

    Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;26:2460-2461.

    Not in our library10.1093/bioinformatics/btq461

37. 37.

    Quast C, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic acids research. 2013;41:D590-D596.

    Not in our library10.1093/nar/gks1219

38. 38.

    Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol. 2005;71:8228-8235.

    Not in our library10.1128/aem.71.12.8228-8235.2005

39. 39.

    Castellarin M, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22:299-306.

    Not in our library10.1101/gr.126516.111

40. 40.

    Astudillo-Garcia C, et al. Evaluating the core microbiota in complex communities: A systematic investigation. Environ Microbiol. 2017;19:1450-1462.

    Not in our library10.1111/1462-2920.13647

41. 41.

    Shetty SA, Hugenholtz F, Lahti L, Smidt H, de Vos WM. Intestinal microbiome landscaping: insight in community assemblage and implications for microbial modulation strategies. FEMS Microbiol Rev. 2017;41:182-199.

    Not in our library10.1093/femsre/fuw045

42. 42.

    Ventura M, et al. Genome-scale analyses of health-promoting bacteria: probiogenomics. Nat Rev Microbiol. 2009;7:61-71.

    Not in our library10.1038/nrmicro2047

43. 43.

    Hidalgo-Cantabrana, C. et al. Bifidobacteria and Their Health-Promoting Effects. Microbiology spectrum5, 10.1128/microbiolspec.BAD-0010-2016 (2017).

    Not in our library10.1128/microbiolspec.bad-0010-2016

44. 44.
    Gut Bifidobacteria Populations in Human Health and Aging · 2016

    No notice
45. 45.

    Duranti, S. et al. Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers. FEMS Microbiol Ecol92, 10.1093/femsec/fiw191 (2016).

    Not in our library10.1093/femsec/fiw191

46. 46.

    Miquel S, et al. Faecalibacterium prausnitzii and human intestinal health. Current opinion in microbiology. 2013;16:255-261.

    Not in our library10.1016/j.mib.2013.06.003

47. 47.

    Rajilic-Stojanovic M, et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology. 2011;141:1792-1801.

    Not in our library10.1053/j.gastro.2011.07.043

48. 48.

    Gerritsen J, et al. Characterization of Romboutsia ilealis gen. nov., sp. nov., isolated from the gastro-intestinal tract of a rat, and proposal for the reclassification of five closely related members of the genus Clostridium into the genera Romboutsia gen. nov., Intestinibacter gen. nov., Terrisporobacter gen. nov. and Asaccharospora gen. nov. Int J Syst Evol Microbiol. 2014;64:1600-1616.

    Not in our library10.1099/ijs.0.059543-0

49. 49.
    Genomic and functional analysis of Romboutsia ilealis CRIB T reveals adaptation to the small intestine · 2017

    No notice
50. 50.

    Ricaboni D, Mailhe M, Khelaifia S, Raoult D, Million M. Romboutsia timonensis, a new species isolated from human gut. New microbes and new infections. 2016;12:6-7.

    Not in our library10.1016/j.nmni.2016.04.001

51. 51.
    Gut microbiota composition and Clostridium difficile infection in hospitalized elderly individuals: a metagenomic study · 2016

    No notice
52. 52.

    Mera RM, et al. Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial. Gut. 2017.

    Not in our library10.1136/gutjnl-2016-311685

53. 53.

    Stecher B, Maier L, Hardt WD. ‘Blooming’ in the gut: how dysbiosis might contribute to pathogen evolution. Nat Rev Microbiol. 2013;11:277-284.

    Not in our library10.1038/nrmicro2989

54. 54.

    Dulal S, Keku TO. Gut microbiome and colorectal adenomas. Cancer journal. 2014;20:225-231.

    Not in our library10.1097/ppo.0000000000000050

55. 55.
    Meta-analysis of gut microbiome studies identifies disease-specific and shared responses · 2017

    No notice
56. 56.

    Mancabelli, L. et al. Identification of universal gut microbial biomarkers of common human intestinal diseases by meta-analysis. FEMS Microbiol Ecol93, 10.1093/femsec/fix153 (2017).

    Not in our library10.1093/femsec/fix153

57. 57.

    Otto CC, Chen LH, He T, Tang YW, Babady NE. Detection of gastrointestinal pathogens in oncology patients by highly multiplexed molecular panels. Eur J Clin Microbiol Infect Dis. 2017;36:1665-1672.

    Not in our library10.1007/s10096-017-2981-0

58. 58.
    Tumor Targeting by Fusobacterium nucleatum: A Pilot Study and Future Perspectives · 2017

    Not checked
59. 59.

    Allali I, et al. Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain. Gut Microbes. 2015;6:161-172.

    Not in our library10.1080/19490976.2015.1039223

60. 60.
    Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology · 2016

    No notice
61. 61.

    Lepage P, et al. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology. 2011;141:227-236.

    Not in our library10.1053/j.gastro.2011.04.011

62. 62.

    Flint HJ, Scott KP, Duncan SH, Louis P, Forano E. Microbial degradation of complex carbohydrates in the gut. Gut Microbes. 2012;3:289-306.

    Not in our library10.4161/gmic.19897

63. 63.

    Akutko K, Matusiewicz K. Campylobacter concisus as the etiologic agent of gastrointestinal diseases. Advances in clinical and experimental medicine: official organ Wroclaw Medical University. 2017;26:149-154.

    Not in our library10.17219/acem/61428

64. 64.
    Co-occurrence of anaerobic bacteria in colorectal carcinomas · 2013

    No notice
65. 65.
    Fusobacterium Is Associated with Colorectal Adenomas · 2013

    No notice
66. 66.

    Kostic AD, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14:207-215.

    Not in our library10.1016/j.chom.2013.07.007

67. 67.

    Bullman S, et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science. 2017;358:1443-1448.

    Not in our library10.1126/science.aal5240

68. 68.

    Chandran P, Satthaporn S, Robins A, Eremin O. Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (I). The surgeon: journal of the Royal Colleges of Surgeons of Edinburgh and Ireland. 2003;1:63-75.

    Not in our library10.1016/s1479-666x(03)80118-x

69. 69.

    Wu S, Morin PJ, Maouyo D, Sears CL. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology. 2003;124:392-400.

    Not in our library10.1053/gast.2003.50047

70. 70.

    Yu T, et al. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell. 2017;170:548-563 e516.

    Not in our library10.1016/j.cell.2017.07.008

71. 71.

    Russell SL, et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO reports. 2012;13:440-447.

    Not in our library10.1038/embor.2012.32

72. 72.
    The Intestinal Microbiome in Early Life: Health and Disease · 2014

    No notice

Cited by papers we hold 2

• Association between residential greenness and gut microbiota in Chinese adults · 2022
  Not checked
• The Molecular Hallmarks of the Serrated Pathway in Colorectal Cancer · 2019
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.